NYSE: MS

MORGAN STANLEY

CIK 0000895421 · SIC 6211 · Security Brokers & Dealers

Mega Revenue $34.3B Assets $1.7T as of Aug 22, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (HPQ 10-Q) is open in full — no account needed.

10-Q Filed Aug 4, 2026 · Period ending Jun 30, 2026

net income $5.58B. Morgan Stanley Q2 2026: Net revenues +57.7%, EPS +62%, ROE 20.7%

5 material changes detected. Sign up free to read the summary.

8-K Filed Jul 15, 2026 · Period ending Jul 15, 2026

Morgan Stanley reports record Q2 revenues of $21.3B, EPS $3.46, raises dividend 15%

5 material changes detected. Sign up free to read the summary.

Partner

Trade MS commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Jun 24, 2026 · Period ending Jun 24, 2026

Morgan Stanley raises dividend 15% to $1.15/share, authorizes $20B buyback program

3 material changes detected. Sign up free to read the summary.

8-K Filed May 15, 2026 · Period ending May 14, 2026

Morgan Stanley shareholders approve all board nominees and executive pay at annual meeting

4 material changes detected. Sign up free to read the summary.

10-Q Filed May 5, 2026 · Period ending Mar 31, 2026

net income $5.57B. Morgan Stanley Q1 2026: 29.0% revenue growth, 21% ROE, and simplified DCP accounting

5 material changes detected. Sign up free to read the summary.

8-K Filed Apr 15, 2026 · Period ending Apr 15, 2026

Morgan Stanley reports Q1 2026 earnings results

2 material changes detected. Sign up free to read the summary.

10-K Filed Feb 19, 2026 · Period ending Dec 31, 2025

net income $16.9B. Morgan Stanley posts 26% earnings jump; balance sheet expands 17% to T

5 material changes detected. Sign up free to read the summary.

8-K Filed Feb 11, 2026 · Period ending Feb 11, 2026

Summary not yet generated.

10-Q Filed Nov 3, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-Q Filed Aug 4, 2025 · Period ending Jun 30, 2025

Summary not yet generated.

10-Q Filed May 5, 2025 · Period ending Mar 31, 2025

Summary not yet generated.

10-K Filed Feb 21, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed Aug 4, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Income Statement (Unaudited)

in millions, except per share data

Description Three months ended June 30, 2026 Three months ended June 30, 2025 Six months ended June 30, 2026 Six months ended June 30, 2025
Revenues
Investment banking 2,651 1,644 4,940 3,355
Trading 6,723 4,745 13,453 9,856
Investments 226 388 372 757
Commissions and fees 1,833 1,425 3,523 2,906
Asset management 6,912 5,953 13,642 11,916
Other 223 290 515 1,041
Total non-interest revenues 18,568 14,445 36,445 29,831
Interest income 15,902 14,905 31,175 28,653
Interest expense 13,122 12,558 25,692 23,953
Net interest 2,780 2,347 5,483 4,700
Net revenues 21,348 16,792 41,928 34,531
Provision for credit losses 98 196 196 331
Non-interest expenses
Compensation and benefits 8,187 7,190 16,729 14,711
Brokerage, clearing and exchange fees 1,464 1,188 2,720 2,410
Information processing and communications 1,203 1,089 2,351 2,139
Professional services 680 711 1,282 1,385
Occupancy and equipment 482 459 965 908
Marketing and business development 401 297 711 535
Other 1,485 1,040 2,615 1,946
Total non-interest expenses 13,902 11,974 27,373 24,034
Income before provision for income taxes 7,348 4,622 14,359 10,166
Provision for income taxes 1,695 1,047 3,068 2,220
Net income 5,653 3,575 11,291 7,946
Net income applicable to noncontrolling interests 72 36 143 92
Net income applicable to Morgan Stanley 5,581 3,539 11,148 7,854
Preferred stock dividends 145 147 301 305
Earnings applicable to Morgan Stanley common shareholders 5,436 3,392 10,847 7,549
Earnings per common share
Basic 3.50 2.15 6.96 4.78
Diluted 3.46 2.13 6.90 4.73
Average common shares outstanding
Basic 1,554 1,577 1,558 1,581
Diluted 1,569 1,593 1,573 1,596

Consolidated Balance Sheet

$ in millions

Description (Unaudited) At June 30, 2026 At December 31, 2025
Assets
Cash and cash equivalents 160,135 111,695
Trading assets at fair value ($278,278 and $213,269 pledged as collateral) 544,153 428,276
Investment securities:
Available-for-sale at fair value (amortized cost of $107,761 and $112,522) 105,532 110,466
Held-to-maturity (fair value of $40,238 and $45,615) 47,747 53,090
Securities purchased under agreements to resell (includes $109 and $— at fair value) 129,516 120,243
Securities borrowed 181,358 151,908
Customer and other receivables 151,010 114,720
Loans:
Held for investment (net of allowance for credit losses of $1,248 and $1,132) 289,318 268,720
Held for sale 13,057 9,374
Goodwill 17,105 16,726
Intangible assets (net of accumulated amortization of $2,042 and $1,882) 5,873 6,010
Other assets 30,253 29,042
Total assets 1,675,057 1,420,270
Liabilities
Deposits (includes $8,647 and $8,755 at fair value) 446,068 415,523
Trading liabilities at fair value 255,589 169,569
Securities sold under agreements to repurchase (includes $887 and $696 at fair value) 102,202 78,539
Securities loaned 20,736 17,310
Other secured financings (includes $19,461 and $16,871 at fair value) 29,819 21,603
Customer and other payables 279,070 226,519
Other liabilities and accrued expenses 31,577 29,620
Borrowings (includes $147,514 and $132,479 at fair value) 392,556 348,935
Total liabilities 1,557,617 1,307,618
Commitments and contingent liabilities (see Note 13)
Equity
Morgan Stanley shareholders’ equity:
Preferred stock 9,750 9,750
Common stock, $0.01 par value:
Shares authorized: 3,500,000,000; Shares issued: 2,038,893,979; Shares outstanding: 1,571,931,108 and 1,582,834,137 20 20
Additional paid-in capital 31,597 31,153
Retained earnings 122,774 115,091
Employee stock trusts 5,912 5,154
Accumulated other comprehensive income (loss) (6,329) (6,285)
Common stock held in treasury at cost, $0.01 par value (466,962,871 and 456,059,842 shares) (41,483) (38,097)
Common stock issued to employee stock trusts (5,912) (5,154)
Total Morgan Stanley shareholders’ equity 116,329 111,632
Noncontrolling interests 1,111 1,020
Total equity 117,440 112,652
Total liabilities and equity 1,675,057 1,420,270

Cash Flow Statement (Unaudited)

$ in millions

Description Six months ended June 30, 2026 Six months ended June 30, 2025
Cash flows from operating activities
Net income 11,291 7,946
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
Stock-based compensation expense 1,133 1,008
Depreciation and amortization 1,916 2,172
Provision for credit losses 196 331
Other operating adjustments 260 156
Changes in assets and liabilities:
Trading assets, net of Trading liabilities (29,728) (65,970)
Securities borrowed (29,450) (16,100)
Securities loaned 3,426 3,967
Customer and other receivables and other assets (40,203) (13,253)
Customer and other payables and other liabilities 56,924 36,316
Securities purchased under agreements to resell (9,273) 11,810
Securities sold under agreements to repurchase 23,663 19,470
Net cash provided by (used for) operating activities (9,845) (12,147)
Cash flows from investing activities
Proceeds from (payments for):
Other assets—Premises, equipment and software (1,573) (1,476)
Changes in loans, net (21,138) (18,186)
AFS securities:
Purchases (16,668) (18,687)
Proceeds from sales 6,878 2,462
Proceeds from paydowns and maturities 14,021 9,111
HTM securities:
Purchases (1,294)
Proceeds from paydowns and maturities 6,901 4,520
Other investing activities (931) (450)
Net cash provided by (used for) investing activities (13,804) (22,706)
Cash flows from financing activities
Net proceeds from (payments for):
Other secured financings 5,095 3,374
Deposits 30,977 13,232
Proceeds from issuance of Borrowings 99,444 69,341
Payments for:
Borrowings (54,037) (45,092)
Repurchases of common stock and employee tax withholdings (4,547) (3,159)
Cash dividends (3,385) (3,200)
Other financing activities (27) 216
Net cash provided by (used for) financing activities 73,520 34,712
Effect of exchange rate changes on cash and cash equivalents (1,431) 3,885
Net increase (decrease) in cash and cash equivalents 48,440 3,744
Cash and cash equivalents, at beginning of period 111,695 105,386
Cash and cash equivalents, at end of period 160,135 109,130
Supplemental Disclosure of Cash Flow Information
Cash payments for:
Interest 26,585 24,543
Income taxes, net of refunds 2,171 2,345

Amounts as printed on the EDGAR/iXBRL face — in millions, except per share data; $ in millions. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

View AI report for this filing